Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-009477

COO & CBO acquired 19,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hexter Joshua COO & CBO 2026-01-22 Option exercise +19,000 1,064,495 D
Derivatives
Hexter Joshua COO & CBO 2026-01-22 Option exercise · Performance Stock Units −19,000 0 D
Loading xslF345X05/ownership.xml…